RxSight Inc (RXST) - Debt to Equity

RXST (RxSight, Inc.) - company brandmark

RxSight, Inc. (RXST) is building a workforce of specialized engineers and sales agents, adhering to strict FDA regulations. The confirmed price history on the chart reflects a total debt-to-equity ratio of 0.04. Financial stability is based on the expansion of adjustable lenses and insurance coverage. The business is developing an environment for personalized vision correction, where specialized devices allow for the adjustment of a patient's vision even after the completion of surgical intervention.

rxsight.com - RXST Debt to Capital (period 07/04/2022 - 10/29/2026)
Flagship merchandise of RxSight Ophthalmic

Business financial stability is determined by the balance between equity and liabilities. This metric measures the proportion of borrowed funds within the capital structure, defining the degree of credit risk. For RxSight, Inc. (RXST), this is critical when scaling the training of surgeons to work with innovative lenses. Assessing the debt load provides insight into the cost of technology expansion. The dynamics of this debt-to-equity ratio reveal the actual level of leverage.

Main competitors

BSX: Debt to Equity|Total Debt to Capital Coefficient EW|RMD - Debt to Equity|Aggregate Debt to Equity Insulet Inc. (PODD)|ZBH: Total Debt to Capital|Debt to Capital coopercos.com COO|ALGN: Total Debt to Capital|GMED - Total Debt to Equity Ratio|TransMedics - Total Debt to Capital|Alphatec Corp (ATEC) - Total Debt to Capital Coefficient|AORT (Artivion, Inc.) - Total Debt to Capital|Total Debt to Capital ENOV|Debt to Equity Integra LifeSciences Holdings Corporation (IART)|Debt to Equity Establishment Labs Corp (ESTA)|Total Debt to Capital BBNX|IRMD - Total Debt to Capital Coefficient|Total Debt to Equity Ratio Embecta Corp.|TNDM - Aggregate Debt to Equity|Total Debt to Capital AXGN|SI-BONE Inc (SIBN) - Debt to Capital|Total Debt to Capital Orthofix International (OFIX)|Debt to Equity Ratio Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio TMCI (treace.com)|Strata Critical Medical - Debt to Equity|Total Debt to Equity Ratio Carlsmed, Inc. CARL|CLPT (ClearPoint) - Total Debt to Capital|STXS - Debt to Capital|Total Debt to Capital Neuronetics, Inc.|sightsciences.com (SGHT) - Debt to Equity Ratio|OBIO: Total Debt to Capital|Total Debt to Capital Coefficient Anika|Total Debt to Capital NSPR (InspireMD Corp)|Total Debt to Equity Ratio zhjmedical.com (ZJYL)|Total Debt to Capital VANI (Vivani Medical)|Xtant Medical Holdings, Inc. - Total Debt to Capital|NMTC - Debt to Equity|Modular Medical (MODD) - Debt to Equity|Total Debt to Equity Ratio Myomo, Inc MYO|Envoy Medical Inc (COCH) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital VVOS (Vivos Therapeutics)|Debt to Capital NVNO|SINT: Debt to Equity|Debt to Capital Ratio Tenon Medical Inc. TNON|Total Debt to Equity Ratio LFWD (ReWalk Robotics Ltd)|Total Debt to Capital Autonomix Medical Inc. AMIX|Total Debt to Capital IVF (INVO Fertility Inc)|BBLG: Total Debt to Capital Coefficient|Debt to Equity Axonics (AXNX)|BIOL (BIOLASE Inc.) - Aggregate Debt to Equity|Debt to Equity DYNT|Total Debt to Equity Ratio Paragon 28 Corp|INVO Bioscience, Inc. - Total Debt to Capital